D-Index & Metrics Best Publications
Immunology
Norway
2022

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 61 Citations 13,274 135 World Ranking 1635 National Ranking 10
Medicine D-index 70 Citations 17,316 170 World Ranking 15620 National Ranking 85

Research.com Recognitions

Awards & Achievements

2022 - Research.com Immunology in Norway Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Immune system
  • Cancer

The scientist’s investigation covers issues in Immunology, Lymphokine-activated killer cell, Interleukin 12, Interleukin 21 and NK Cell Lectin-Like Receptor Subfamily C. Karl-Johan Malmberg has included themes like Cancer research and Transplantation in his Immunology study. His Lymphokine-activated killer cell study incorporates themes from Natural killer cell and Cell biology.

His research investigates the link between Cell biology and topics such as Cytotoxic T cell that cross with problems in DNA methylation, Effector and Acquired immune system. The concepts of his NK Cell Lectin-Like Receptor Subfamily C study are interwoven with issues in Virus and Innate immune system. His Virus study deals with Human leukocyte antigen intersecting with KIR2DS4.

His most cited work include:

  • Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education (487 citations)
  • Prospects for the use of NK cells in immunotherapy of human cancer (447 citations)
  • Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function. (397 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Immunology, Cell, Cell biology, Cytotoxic T cell and Natural killer cell. His studies examine the connections between Immunology and genetics, as well as such issues in Interleukin 12, with regards to Acquired immune system. His Cell research is multidisciplinary, relying on both Cancer research, Cytokine, Cancer immunotherapy, Receptor and Interleukin 15.

His research integrates issues of Phenotype and Reprogramming in his study of Cell biology. His Cytotoxic T cell research is multidisciplinary, incorporating elements of T cell, Degranulation and CD8. His work carried out in the field of Natural killer cell brings together such families of science as Gene and Major histocompatibility complex.

He most often published in these fields:

  • Immunology (101.99%)
  • Cell (73.63%)
  • Cell biology (74.13%)

What were the highlights of his more recent work (between 2018-2021)?

  • Cell (73.63%)
  • Cell biology (74.13%)
  • Cancer research (33.83%)

In recent papers he was focusing on the following fields of study:

Karl-Johan Malmberg spends much of his time researching Cell, Cell biology, Cancer research, Natural killer cell and Cell therapy. His Cell research incorporates elements of Cytokine, Cancer immunotherapy, Perforin, Innate immune system and Interleukin 15. Innate immune system is a subfield of Immunology that Karl-Johan Malmberg investigates.

The Cell biology study combines topics in areas such as Cytotoxic T cell, Granzyme B and In vivo. Karl-Johan Malmberg has researched Cytotoxic T cell in several fields, including Cell culture, Human leukocyte antigen and Stem cell. He regularly links together related areas like Receptor in his Natural killer cell studies.

Between 2018 and 2021, his most popular works were:

  • Natural killer cell immunotypes related to COVID-19 disease severity. (66 citations)
  • Natural killer cell immunotypes related to COVID-19 disease severity. (66 citations)
  • Natural killer cell immunotypes related to COVID-19 disease severity. (66 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Immune system
  • Cancer

Karl-Johan Malmberg mostly deals with Cell, Receptor, Cell biology, Innate immune system and Natural killer cell. His work in the fields of Cell, such as Cell therapy, intersects with other areas such as Induced pluripotent stem cell. His studies deal with areas such as Bile duct cancer, Immunology, Immune system, Liver cancer and Primary sclerosing cholangitis as well as Receptor.

His work in Cell biology addresses subjects such as Interleukin 15, which are connected to disciplines such as Immunotherapy and Cell culture. His biological study spans a wide range of topics, including Cytokine, Cell type, Granzyme B, Intracellular and Degranulation. His PI3K/AKT/mTOR pathway study combines topics in areas such as Reprogramming and Cytotoxic T cell.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Prospects for the use of NK cells in immunotherapy of human cancer

Hans-Gustaf Ljunggren;Karl-Johan Malmberg.
Nature Reviews Immunology (2007)

587 Citations

Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education

Niklas K. Björkström;Peggy Riese;Frank Heuts;Sandra Andersson.
Blood (2010)

559 Citations

Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus

Niklas K. Björkström;Therese Lindgren;Malin Stoltz;Cyril Fauriat;Cyril Fauriat.
Journal of Experimental Medicine (2011)

412 Citations

Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function.

Heinrich Schlums;Frank M Cichocki;Frank M Cichocki;Bianca Tesi;Jakob Theorell.
Immunity (2015)

399 Citations

NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRS

Vivien Béziat;Lisa L. Liu;Jenny-Ann Malmberg;Martin A. Ivarsson.
Blood (2013)

361 Citations

CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients.

Vivien Béziat;Vivien Béziat;Vivien Béziat;Olav Dalgard;Tarik Asselah;Philippe Halfon.
European Journal of Immunology (2012)

280 Citations

Education of human natural killer cells by activating killer cell immunoglobulin-like receptors

Cyril Fauriat;Martin A. Ivarsson;Hans-Gustaf Ljunggren;Karl-Johan Malmberg.
Blood (2010)

273 Citations

DNAX Accessory Molecule-1 Mediated Recognition of Freshly Isolated Ovarian Carcinoma by Resting Natural Killer Cells

Mattias Carlsten;Niklas K. Björkström;Håkan Norell;Yenan Bryceson.
Cancer Research (2007)

255 Citations

Identification of new HER2/neu-derived peptide epitopes that can elicit specific CTL against autologous and allogeneic carcinomas and melanomas.

Yang Rongcun;Flavio Salazar-Onfray;Jehad Charo;Karl Johan Malmberg.
Journal of Immunology (1999)

236 Citations

IFN-γ protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism

Karl Johan Malmberg;Victor Levitsky;Håkan Norell;Cristina Teixeira De Matos.
Journal of Clinical Investigation (2002)

232 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Karl-Johan Malmberg

Lorenzo Moretta

Lorenzo Moretta

Bambino Gesù Children's Hospital

Publications: 87

Jeffrey S. Miller

Jeffrey S. Miller

University of Minnesota

Publications: 74

Alessandro Moretta

Alessandro Moretta

University of Genoa

Publications: 62

Yenan T. Bryceson

Yenan T. Bryceson

University of Bergen

Publications: 57

Hans-Gustaf Ljunggren

Hans-Gustaf Ljunggren

Karolinska Institute

Publications: 54

Zhigang Tian

Zhigang Tian

University of Science and Technology of China

Publications: 43

Franco Locatelli

Franco Locatelli

Bambino Gesù Children's Hospital

Publications: 42

Peter Parham

Peter Parham

Stanford University

Publications: 39

Christian Münz

Christian Münz

University of Zurich

Publications: 39

Adelheid Cerwenka

Adelheid Cerwenka

Heidelberg University

Publications: 38

Eric Vivier

Eric Vivier

Aix-Marseille University

Publications: 37

Angela Santoni

Angela Santoni

Sapienza University of Rome

Publications: 35

Maria Cristina Mingari

Maria Cristina Mingari

University of Genoa

Publications: 35

Joseph C. Sun

Joseph C. Sun

Memorial Sloan Kettering Cancer Center

Publications: 34

Miguel López-Botet

Miguel López-Botet

Pompeu Fabra University

Publications: 31

Simona Sivori

Simona Sivori

University of Genoa

Publications: 31

Something went wrong. Please try again later.